Mark Wing

Monoclonal antibody treatment exposes three mechanisms underlying the clinical course of multiple sclerosis

Alasdair Coles, Mark Wing, Paul Molyneux et al. · Annals of Neurology · 1999 · 498 citations

Life Sciences, Neurology, Neuroscience +16

Pulsed monoclonal antibody treatment and autoimmune thyroid disease in multiple sclerosis

Alasdair Coles, Mark Wing, Sheila I. Smith et al. · The Lancet · 1999 · 458 citations

Life Sciences, Immunology, Neurology +14

Mechanism of first-dose cytokine-release syndrome by CAMPATH 1-H: involvement of CD16 (FcgammaRIII) and CD11a/CD18 (LFA-1) on NK cells.

Mark Wing, T. Moreau, Judith Greenwood et al. · Journal of Clinical Investigation · 1996 · 257 citations · Full text

Life Sciences, Cell Biology, Immunology +17

Transient increase in symptoms associated with cytokine release in patients with multiple sclerosis

Thibault Moreau, Alasdair Coles, Mark Wing et al. · Brain · 1996 · 251 citations

Life Sciences, Immunology, Neurology +17

Preliminary evidence from magnetic resonance imaging for reduction in disease activity after lymphocyte depletion in multiple sclerosis

T. Moreau, Neil Scolding, Alastair Compston et al. · The Lancet · 1994 · 187 citations

Life Sciences, Immunology, Neurology +15